IP Library Granted Patent US 12,138,310
Granted Patent B2
US 12,138,310 · App. 16/753,482 · Granted Nov 12, 2024

Processing method for biopolymers using solvent combinations

Inventors: Richard Dolph Andersen (Berlin, DE); Annette Assogba-Zandt (Berlin, DE); Elena Maltseva (Schöneiche, DE); Andreas Voigt (Berlin, DE)
Assignee: SolyPlus GmbH
A61K47/36A61K9/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,138,310
App. No.
16/753,482
Granted
Nov 12, 2024
Kind
B2
Abstract

The invention relates primarily to a processing method of biopolymers by means of solvent/solvent mixtures or multiphase solvent systems by means of which said polymers can be changed in their mechanical and qualitative features and processed more easily.

Claims (16)

1. A method of processing a biopolymer, comprising:

providing the biopolymer in dry particulate form, wherein the biopolymer is hyaluronic acid or a hyaluronate salt;

optionally providing at least one active pharmaceutical ingredient;

providing a single-phase solvent solution consisting of 30%-40% water and 60%-70% isopropanol or ethanol;

combining the biopolymer in dry particulate form with the single-phase solvent solution, and optionally the at least one active pharmaceutical ingredient; and

mixing the combined mixture by mechanical means to produce a biopolymer matrix having a homogenous swelling.

2. The method of claim 1 , further comprising removing excess isopropanol or ethanol from the produced biopolymer matrix by pressure and/or air circulation.

3. The method of claim 1 , further comprising forming a pressed body from the biopolymer matrix.

4. The method of claim 3 , wherein the pressed body is microneedles or a film.

5. The method of claim 1 , further comprising pressing the biopolymer matrix in a cavity or mold, and drying and/or solidifying before or after removal from the cavity or mold.

6. The method of claim 5 , wherein the cavity or mold is shaped for microneedles.

7. The method of claim 1 , further comprising forming a film from the biopolymer matrix.

8. The method of claim 7 , further comprising applying the film to a bandage or plaster base.

9. The method of claim 1 , wherein the biopolymer in dry particulate form and the single-phase solvent solution are combined in an amount of about 0.60-0.61 g biopolymer to about 1 ml solvent solution.

10. The method of claim 1 , wherein the at least one active pharmaceutical ingredient is provided.

11. The method of claim 1 , wherein the method is carried out under sterile conditions to produce a sterile biopolymer matrix.

Assignments (2)
CHANGE OF NAME Recorded Sep 25, 2020
From: SOLYPLUS BERLIN GMBH
To: SOLYPLUS GMBH
Reel/Frame 053893/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2020
From: ANDERSEN, RICHARD DOLPH; ASSOGBA-ZANDT, ANNETTE; MALTSEVA, ELENA; VOIGT, ANDREAS
To: SOLYPLUS BERLIN GMBH
Reel/Frame 052305/0179 →
Priority Claims (1)
DE 102017009801.8 · Oct 12, 2017 · national
Continuity (1)
Related Publication 20200254102A1 · Aug 13, 2020